Evidence map›Paper›PMID 28195225›Full record

ArticleScientific reports2017

A novel BK channel-targeted peptide suppresses sound evoked activity in the mouse inferior colliculus.

L L Scott, E J Brecht, A Philpo, S Iyer, N S Wu, S J Mihic, R W Aldrich, J Pierce, J P Walton

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Extracellular vesicles for developing targeted hearing loss therapy.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Auditory brainstem responses in the red-eared slider Trachemys scripta elegans (Testudoformes: Emydidae) reveal sexually dimorphic hearing sensitivity.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2019
    Article
  8. A Novel Peptide Restricts Ethanol Modulation of the BK Channel In Vitro and In Vivo.The Journal of pharmacology and experimental therapeutics · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

L L ScottWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, USA.
E J BrechtDepartment of Chemical &Biomedical Engineering, University of South Florida, Tampa, USA.
A PhilpoWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, USA.
S IyerWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, USA.
N S WuWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, USA.
S J MihicWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, USA.
R W AldrichCenter for Learning and Memory, University of Texas at Austin, Austin, USA.
J PierceWaggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, USA.
J P WaltonDepartment of Chemical &Biomedical Engineering, University of South Florida, Tampa, USA.
The University of Texas at Austin · USUniversity of South Florida · US

Funding

Structure and Function Services CoreP01AG009524 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI FRISINA, ROBERT D · 1992 to 2021
$23.2M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Novel molecular and cellular approaches for alcoholism medication developmentP01AA020683 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI MIHIC, S JOHN · 2012 to 2016
$3.3M
A screen for peptides that alter BK channel-mediated alcohol intoxicationR01AA020992 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI ALDRICH, RICHARD, MIHIC, S JOHN · 2012 to 2016
$2.0M
NIAAA NIH HHS P01 AA020683NIAAA NIH HHS R01 AA020992NIA NIH HHS P01 AG009524NIH HHS P40 OD010440
6 · The paper itself

Abstract

Large conductance calcium-activated (BK) channels are broadly expressed in neurons and muscle where they modulate cellular activity. Decades of research support an interest in pharmaceutical applications for modulating BK channel function. Here we report a novel BK channel-targeted peptide with functional activity in vitro and in vivo. This 9-amino acid peptide, LS3, has a unique action, suppressing channel gating rather than blocking the pore of heterologously expressed human BK channels. With an IC

Indexed as

Amino Acid SequenceAnimalsBrain StemCell LineEvoked Potentials, AuditoryHumansInferior ColliculiIon Channel GatingLarge-Conductance Calcium-Activated Potassium ChannelsMesencephalonMicePeptidesPotassium Channel BlockersLarge-Conductance Calcium-Activated Potassium ChannelsPeptidesPotassium Channel Blockers

Identifiers

PMID28195225
PMCPMC5307958
OpenAlexW2587955890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.